Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Beximco Pharmaceuticals Limited has announced a substantial increase in its financial performance, with net profit after tax rising to Tk. 5,866,771,470 for the year ended June 2024, compared to Tk. 4,524,468,490 the previous year. The company also declared a 40% cash dividend and proposed a name change to Beximco Pharmaceuticals PLC, pending shareholder approval at the upcoming AGM. These developments highlight Beximco’s robust growth trajectory and commitment to shareholder value.
For further insights into GB:BXP stock, check out TipRanks’ Stock Analysis page.
